InsiderTrades.com logo

VRTX Insider Trading

Insider Ownership Percentage: 0.20%
Insider Buying (Last 12 Months): $1,948,400.00
Insider Selling (Last 12 Months): $111,316,485.39

Vertex Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Vertex Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vertex Pharmaceuticals Share Price & Price History

Current Price: $454.04
Price Change: ▼ Price Decrease of -4.011 (-0.88%)
As of 03/20/2026 04:59 PM ET

This chart shows the closing price history over time for VRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vertex Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2026Carmen BozicCMOSell2,329$481.79$1,122,088.9135,405View SEC Filing Icon  
2/25/2026Amit SachdevEVPSell1,846$486.35$897,802.1055,570View SEC Filing Icon  
2/25/2026Duncan McKechnieEVPSell4,910$487.65$2,394,361.5017,559View SEC Filing Icon  
2/25/2026E. Morrey Atkinson, IIIEVPSell668$486.35$324,881.8018,432View SEC Filing Icon  
2/25/2026Jonathan BillerEVPSell945$486.35$459,600.7513,659View SEC Filing Icon  
2/25/2026Kristen AmbroseCAOSell223$486.35$108,456.056,981View SEC Filing Icon  
2/25/2026Mark E. BunnageEVPSell620$486.35$301,537.007,284View SEC Filing Icon  
2/25/2026Ourania TatsisEVPSell260$486.35$126,451.0046,763View SEC Filing Icon  
2/19/2026Amit SachdevEVPSell58,613$468.83$27,479,532.7958,934View SEC Filing Icon  
2/13/2026Ourania TatsisEVPSell1,500$499.99$749,985.0046,132View SEC Filing Icon  
2/11/2026E. Morrey Atkinson, IIIEVPSell1,751$460.43$806,212.9322,046View SEC Filing Icon  
2/11/2026Jonathan BillerEVPSell1,925$460.43$886,327.7520,819View SEC Filing Icon  
2/11/2026Kristen AmbroseCAOSell1,376$460.43$633,551.6810,127View SEC Filing Icon  
2/11/2026Mark E. BunnageEVPSell2,021$460.43$930,529.0312,914View SEC Filing Icon  
2/11/2026Ourania TatsisEVPSell466$460.43$214,560.3851,436View SEC Filing Icon  
1/7/2026Ourania TatsisEVPSell4,500$474.99$2,137,455.0042,293View SEC Filing Icon  
1/6/2026Charles F. Wagner, Jr.EVPSell9,532$461.00$4,394,252.0037,725View SEC Filing Icon  
12/3/2025Charles F. Wagner, Jr.EVPSell14,000$456.00$6,384,000.0037,725View SEC Filing Icon  
12/3/2025Jeffrey M. LeidenChairmanSell63,781$449.20$28,650,425.2024,026View SEC Filing Icon  
11/14/2025Jeffrey M. LeidenChairmanSell53,604$440.72$23,624,354.8824,026View SEC Filing Icon  
11/13/2025Jeffrey M. LeidenChairmanSell19,688$440.27$8,668,035.7624,026View SEC Filing Icon  
8/6/2025Bruce I. SachsDirectorBuy5,000$389.68$1,948,400.0045,000View SEC Filing Icon  
5/15/2025David AltshulerEVPSell52$424.69$22,083.8823,281View SEC Filing Icon  
3/10/2025David AltshulerEVPSell3,231$500.00$1,615,500.0026,512View SEC Filing Icon  
2/27/2025Ourania TatsisEVPSell530$475.34$251,930.2058,539View SEC Filing Icon  
2/18/2025Ourania TatsisEVPSell244$455.06$111,034.6467,695View SEC Filing Icon  
2/11/2025Ourania TatsisEVPSell310$459.83$142,547.3064,021View SEC Filing Icon  
11/15/2024David AltshulerEVPSell15$478.56$7,178.4025,813View SEC Filing Icon  
8/30/2024Jeffrey M. LeidenChairmanSell3,784$499.00$1,888,216.009,994View SEC Filing Icon  
8/30/2024Sangeeta N BhatiaDirectorSell646$500.00$323,000.004,435View SEC Filing Icon  
8/7/2024Carmen BozicCMOSell2,280$476.75$1,086,990.0023,259View SEC Filing Icon  
8/1/2024Bruce I. SachsDirectorSell5,295$508.00$2,689,860.0040,000View SEC Filing Icon  
7/24/2024Carmen BozicCMOSell2,280$488.46$1,113,688.8025,539View SEC Filing Icon  
7/22/2024Reshma KewalramaniCEOSell15,202$497.00$7,555,394.00106,172View SEC Filing Icon  
7/10/2024Carmen BozicCMOSell2,280$487.34$1,111,135.2027,819View SEC Filing Icon  
6/26/2024Carmen BozicCMOSell2,280$471.72$1,075,521.6030,099View SEC Filing Icon  
6/12/2024Carmen BozicCMOSell2,280$478.00$1,089,840.0032,379View SEC Filing Icon  
6/12/2024E. Morrey Atkinson, IIIEVPSell7,288$478.00$3,483,664.0015,972View SEC Filing Icon  
5/30/2024Ourania TatsisEVPSell2,350$439.11$1,031,908.5053,523View SEC Filing Icon  
5/29/2024Carmen BozicCMOSell2,280$445.56$1,015,876.8034,659View SEC Filing Icon  
5/28/2024Charles F. Wagner, Jr.CFOSell3,250$454.79$1,478,067.5050,387View SEC Filing Icon  
5/24/2024Reshma KewalramaniCEOSell1,565$457.00$715,205.00121,374View SEC Filing Icon  
5/22/2024Bruce I. SachsDirectorSell7,073$448.00$3,168,704.0040,000View SEC Filing Icon  
2/26/2024Ourania TatsisEVPSell354$425.70$150,697.8055,804View SEC Filing Icon  
2/20/2024Ourania TatsisEVPSell480$420.79$201,979.2059,827View SEC Filing Icon  
2/12/2024Amit SachdevEVPSell3,222$420.24$1,354,013.2874,364View SEC Filing Icon  
2/12/2024Jeffrey M. LeidenChairmanSell2,656$419.51$1,114,218.5627,644View SEC Filing Icon  
2/12/2024Kristen AmbroseCAOSell1,374$420.24$577,409.769,676View SEC Filing Icon  
2/12/2024Stuart A. ArbuckleCOOSell4,295$420.24$1,804,930.8075,718View SEC Filing Icon  
1/8/2024Jeffrey M. LeidenChairmanSell6,648$419.07$2,785,977.362,423View SEC Filing Icon  
11/6/2023Bruce I. SachsDirectorSell11,250$385.00$4,331,250.0040,000View SEC Filing Icon  
10/31/2023Carmen BozicCMOSell5,651$355.92$2,011,303.9234,952View SEC Filing Icon  
10/17/2023Carmen BozicCMOSell5,651$373.25$2,109,235.7540,603View SEC Filing Icon  
10/17/2023Sangeeta N BhatiaDirectorSell243$375.00$91,125.003,901View SEC Filing Icon  
10/16/2023Jeffrey M. LeidenChairmanSell12,962$374.00$4,847,788.0022,425View SEC Filing Icon  
10/6/2023Sangeeta N BhatiaDirectorSell242$360.00$87,120.004,144View SEC Filing Icon  
10/3/2023Carmen BozicCMOSell5,651$345.28$1,951,177.2846,254View SEC Filing Icon  
10/2/2023Jonathan BillerEVPSell610$346.76$211,523.6010,569View SEC Filing Icon  
9/19/2023Carmen BozicCMOSell5,651$351.00$1,983,501.0051,905View SEC Filing Icon  
8/23/2023Ourania TatsisEVPSell2,500$355.00$887,500.0048,637View SEC Filing Icon  
8/9/2023David AltshulerEVPSell63$345.51$21,767.1332,038View SEC Filing Icon  
8/9/2023Sangeeta N BhatiaDirectorSell242$345.51$83,613.424,386View SEC Filing Icon  
7/17/2023Bruce I. SachsDirectorSell11,250$356.75$4,013,437.5040,000View SEC Filing Icon  
7/17/2023Reshma KewalramaniCEOSell7,828$355.00$2,778,940.00118,906View SEC Filing Icon  
6/15/2023Stuart A. ArbuckleCOOSell8,603$349.00$3,002,447.0056,556View SEC Filing Icon  
5/30/2023Kristen AmbroseCAOSell289$329.82$95,317.986,838View SEC Filing Icon  
5/30/2023Stuart A. ArbuckleCOOSell82$329.82$27,045.2456,556View SEC Filing Icon  
5/8/2023Bastiano SannaEVPSell2,850$350.00$997,500.0032,038View SEC Filing Icon  
5/8/2023Jeffrey M. LeidenChairmanSell1,125$349.00$392,625.0035,387View SEC Filing Icon  
5/5/2023Bastiano SannaEVPSell422$350.03$147,712.6634,888View SEC Filing Icon  
5/5/2023Jeffrey M. LeidenChairmanSell879$349.56$307,263.2436,512View SEC Filing Icon  
5/2/2023Bastiano SannaEVPSell1,622$350.66$568,770.5238,091View SEC Filing Icon  
5/2/2023Jeffrey M. LeidenChairmanSell6,450$349.89$2,256,790.5041,899View SEC Filing Icon  
5/2/2023Sangeeta N BhatiaDirectorSell580$348.28$202,002.404,628View SEC Filing Icon  
4/27/2023Reshma KewalramaniCEOSell3,317$339.08$1,124,728.36126,652View SEC Filing Icon  
4/12/2023Bastiano SannaEVPSell7,567$326.70$2,472,138.9039,713View SEC Filing Icon  
4/12/2023Bruce I. SachsDirectorSell21,300$326.73$6,959,349.0041,210View SEC Filing Icon  
4/4/2023Bastiano SannaEVPSell522$315.81$164,852.8247,280View SEC Filing Icon  
3/24/2023Charles F. Wagner, Jr.CFOSell1,768$305.38$539,911.8449,611View SEC Filing Icon  
3/17/2023Charles F. Wagner, Jr.CFOSell2,000$296.39$592,780.0051,379View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VRTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vertex Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Purpose Unlimited Inc.835$0.38M0.0%N/A0.000%Search for SEC Filing on Google Icon
3/17/2026Cornerstone Planning LLC450$0.20M0.0%N/A0.000%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.135,232$61.31M0.1%+45.7%0.053%Search for SEC Filing on Google Icon
3/13/2026World Investment Advisors1,972$0.89M0.0%+37.8%0.001%Search for SEC Filing on Google Icon
3/11/2026Meadowbrook Advisors Group LLC1,151$0.52M0.3%N/A0.000%Search for SEC Filing on Google Icon
3/11/2026Larry Mathis Financial Planning LLC1,693$0.77M0.7%N/A0.001%Search for SEC Filing on Google Icon
3/10/2026PeakShares LLC2,244$1.02M1.0%N/A0.001%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC102,570$46.51M0.1%+0.8%0.040%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC630,289$285.89M0.2%-1.6%0.248%Search for SEC Filing on Google Icon
3/5/2026Mengis Capital Management Inc.500$0.23M0.0%N/A0.000%Search for SEC Filing on Google Icon
3/4/2026Pure Financial Advisors LLC3,110$1.41M0.0%-6.6%0.001%Search for SEC Filing on Google Icon
3/4/2026Rehmann Capital Advisory Group1,937$0.88M0.0%+3.3%0.001%Search for SEC Filing on Google Icon
3/4/2026SHP Wealth Management486$0.22M0.0%N/A0.000%Search for SEC Filing on Google Icon
3/4/2026Stenger Family Office LLC7,323$3.32M0.7%-31.7%0.003%Search for SEC Filing on Google Icon
3/3/2026S Harris Financial Group LLC461$0.21M0.2%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Reflection Asset Management288$0.13M0.1%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Sankala Group LLC233$0.12M0.1%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Tobam1,154$0.52M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/27/2026Groupama Asset Managment163,144$73.96M1.1%+276.1%0.064%Search for SEC Filing on Google Icon
2/26/2026Anchor Investment Management LLC495$0.22M0.0%-79.3%0.000%Search for SEC Filing on Google Icon
2/26/2026Banque Transatlantique SA539$0.24M0.0%-12.2%0.000%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank131$59K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026DGS Capital Management LLC1,161$0.53M0.1%+35.9%0.000%Search for SEC Filing on Google Icon
2/24/2026SG Trading Solutions LLC544$0.25M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.76,142$34.52M0.1%+14.5%0.030%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC1,493$0.68M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/23/2026MV Capital Management Inc.189$86K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2026Cambient Family Office LLC582$0.26M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2026Kovitz Investment Group Partners LLC98,375$44.60M1.0%+22.1%0.039%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.6,541$2.97M0.1%+174.4%0.003%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.2,152,672$975.94M0.1%+2.7%0.847%Search for SEC Filing on Google Icon
2/19/2026Rare Wolf Capital LLC2,015$0.91M0.6%N/A0.001%Search for SEC Filing on Google Icon
2/19/2026Axxcess Wealth Management LLC565$0.26M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC112,138$46.35M0.0%+10.2%0.044%Search for SEC Filing on Google Icon
2/18/2026Alpine Woods Capital Investors LLC1,402$0.64M0.2%-68.3%0.001%Search for SEC Filing on Google Icon
2/18/2026Strive Financial Group LLC113$51K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Ameriflex Group Inc.166$75K0.0%-13.5%0.000%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV23,822$10.80M0.0%+26.8%0.009%Search for SEC Filing on Google Icon
2/18/2026Summit Global Investments4,204$1.91M0.1%-15.5%0.002%Search for SEC Filing on Google Icon
2/18/2026Blue Chip Partners LLC1,691$0.77M0.1%+23.0%0.001%Search for SEC Filing on Google Icon
2/18/2026Raymond James Financial Inc.418,131$189.56M0.1%-21.9%0.165%Search for SEC Filing on Google Icon
2/18/2026Virtue Capital Management LLC529$0.24M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Onyx Bridge Wealth Group LLC491$0.22M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC13,685$6.21M0.1%+3.5%0.005%Search for SEC Filing on Google Icon
2/18/2026Beacon Pointe Advisors LLC13,502$6.12M0.0%+1.6%0.005%Search for SEC Filing on Google Icon
2/18/2026First Citizens Bank & Trust Co.910$0.41M0.0%-44.5%0.000%Search for SEC Filing on Google Icon
2/18/2026Wahed Invest LLC6,771$3.07M0.4%-0.4%0.003%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury80,373$37.77M0.1%-7.4%0.032%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC8,946$4.06M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp63,299$28.67M0.0%+16.5%0.025%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC17,335$7.86M0.0%+47.9%0.007%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC13,716$6.22M0.5%+95.9%0.005%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC14,806$6.71M0.1%+9.0%0.006%Search for SEC Filing on Google Icon
2/18/2026Garton & Associates Financial Advisors LLC278$0.13M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management56,626$25.67M0.2%-2.4%0.022%Search for SEC Filing on Google Icon
2/18/2026Zurich Insurance Group Ltd FI48,699$22.08M0.2%N/A0.019%Search for SEC Filing on Google Icon
2/18/2026Kensington Investment Counsel LLC1,574$0.71M0.3%+3.1%0.001%Search for SEC Filing on Google Icon
2/18/2026VestGen Advisors LLC2,027$0.92M0.0%-20.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC1,511$0.69M0.2%+56.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Strategic Investment Advisors MI1,511$0.69M0.1%-8.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP3,821,731$1.73B0.6%-19.9%1.506%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.7,231$3.28M0.1%-9.1%0.003%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC29,189$13.23M0.2%+9.0%0.012%Search for SEC Filing on Google Icon
2/18/2026Toronto Dominion Bank91,288$41.39M0.1%-13.0%0.036%Search for SEC Filing on Google Icon
2/18/2026Somerville Kurt F23,327$10.58M1.8%+3.0%0.009%Search for SEC Filing on Google Icon
2/18/2026Summit Securities Group LLC763$0.35M0.0%+808.3%0.000%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC1,460$0.66M0.1%-29.9%0.001%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd1,303$0.59M0.0%-99.1%0.001%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP1,522$0.69M0.3%N/A0.001%Search for SEC Filing on Google Icon
2/18/2026Man Group plc380,735$172.61M0.3%+5.0%0.150%Search for SEC Filing on Google Icon
2/18/2026IHT Wealth Management LLC1,463$0.66M0.0%-5.1%0.001%Search for SEC Filing on Google Icon
2/18/2026Investment Management Corp of Ontario22,300$10.11M0.1%+46.4%0.009%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC2,221,953$1.01B0.5%+4.9%0.876%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC21,511$9.75M0.0%-1.7%0.008%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP4,664$2.11M0.0%-68.6%0.002%Search for SEC Filing on Google Icon
2/18/2026First Manhattan CO. LLC.2,059$0.93M0.0%+30.3%0.001%Search for SEC Filing on Google Icon
2/18/2026Capitolis Liquid Global Markets LLC12,815$5.81M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/18/2026Aristotle Atlantic Partners LLC38,391$17.41M0.8%-3.5%0.015%Search for SEC Filing on Google Icon
2/18/2026Aureus Asset Management LLC6,142$2.79M0.2%+237.8%0.002%Search for SEC Filing on Google Icon
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.93,837$42.58M0.3%-4.4%0.037%Search for SEC Filing on Google Icon
2/18/2026Align Financial LLC4,534$2.06M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC101,041$45.81M0.3%-2.0%0.040%Search for SEC Filing on Google Icon
2/17/2026Caisse de depot et placement du Quebec113,768$51.58M0.1%-48.8%0.045%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC13,716$6.22M0.4%+95.9%0.005%Search for SEC Filing on Google Icon
2/17/2026Integrated Advisors Network LLC2,174$0.99M0.0%-23.7%0.001%Search for SEC Filing on Google Icon
2/17/2026DV Equities LLC358$0.16M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC143,651$65.13M0.0%-11.2%0.057%Search for SEC Filing on Google Icon
2/17/2026GAM Holding AG9,552$4.33M0.3%-13.3%0.004%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC1,360$0.62M0.1%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026EFG International AG687$0.31M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC198,950$90.20M0.2%-63.5%0.078%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers75,013$34.01M0.0%-3.5%0.030%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC24,978$11.32M0.1%N/A0.010%Search for SEC Filing on Google Icon
2/17/2026Hilltop Holdings Inc.3,015$1.37M0.1%-38.9%0.001%Search for SEC Filing on Google Icon
2/17/2026Equitable Holdings Inc.2,170$0.98M0.0%-15.2%0.001%Search for SEC Filing on Google Icon
2/17/2026Laird Norton Wetherby Trust Company LLC11,757$5.33M0.1%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026Kovack Advisors Inc.6,191$2.81M0.1%+439.8%0.002%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP46,053$20.88M0.2%+750.3%0.018%Search for SEC Filing on Google Icon
2/17/2026Amundi1,304,161$591.25M0.2%+16.6%0.514%Search for SEC Filing on Google Icon
2/17/2026iSAM Funds UK Ltd3,221$1.46M0.5%+157.7%0.001%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vertex Pharmaceuticals logo
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Read More on Vertex Pharmaceuticals

Today's Range

Now: $454.04
Low: $452.89
High: $461.05

50 Day Range

MA: $469.17
Low: $438.92
High: $499.17

52 Week Range

Now: $454.04
Low: $362.50
High: $513.97

Volume

2,200,118 shs

Average Volume

1,394,594 shs

Market Capitalization

$115.34 billion

P/E Ratio

29.62

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top insider shareholders include:
  1. Reshma Kewalramani (CEO)
  2. Ourania Tatsis (EVP)
  3. Amit Sachdev (EVP)
  4. Charles F Wagner Jr (CFO)
  5. Bruce I Sachs (Director)
  6. Charles F Wagner Jr (EVP)
  7. Carmen Bozic (CMO)
  8. David Altshuler (EVP)
  9. Jeffrey M Leiden (Chairman)
  10. Edward Morrow Atkinson III (EVP)
  11. Jonathan Biller (EVP)
  12. Duncan Mckechnie (EVP)
  13. Mark E Bunnage (EVP)
  14. Kristen Ambrose (CAO)
  15. Sangeeta N Bhatia (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.

Who are the major institutional investors of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top institutional investors include:
  1. Capital World Investors — 10.05%
  2. Vanguard Group Inc. — 9.50%
  3. Capital Research Global Investors — 6.82%
  4. State Street Corp — 4.61%
  5. Geode Capital Management LLC — 2.36%
  6. Capital International Investors — 1.87%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.

Which major investors are selling Vertex Pharmaceuticals stock?

Within the previous quarter, VRTX stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. Price T Rowe Associates Inc. MD
  3. Edgewood Management LLC
  4. Capital World Investors
  5. Lazard Asset Management LLC
  6. Massachusetts Financial Services Co. MA
  7. Renaissance Technologies LLC
  8. Adage Capital Partners GP L.L.C.
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
  1. Reshma Kewalramani (CEO)
  2. Ourania Tatsis (EVP)
  3. Amit Sachdev (EVP)
  4. Charles F Wagner Jr (CFO)
  5. Bruce I Sachs (Director)
  6. Charles F Wagner Jr (EVP)
  7. Carmen Bozic (CMO)
  8. David Altshuler (EVP)
  9. Jeffrey M Leiden (Chairman)
  10. Edward Morrow Atkinson III (EVP)
  11. Jonathan Biller (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.

Which major investors are buying Vertex Pharmaceuticals stock?

During the previous quarter, VRTX stock was acquired by institutional investors including:
  1. Norges Bank
  2. Victory Capital Management Inc.
  3. Capital Research Global Investors
  4. Life Cycle Investment Partners Ltd
  5. Los Angeles Capital Management LLC
  6. Clearbridge Investments LLC
  7. Arrowstreet Capital Limited Partnership
  8. B. Metzler seel. Sohn & Co. AG